-Masahiro Fukuoka Researcher Activity Profile

Research Author Detailed Information 

Masahiro Fukuoka Publication Rate By Year

Masahiro Fukuoka has published 8 paper(s) in 2007, 3 paper(s) in 2008, for a total of 11 research publications in total.

Masahiro M Fukuoka Author Information

LAST NAME: fukuoka

FIRST NAME: masahiro

INITIALS: M

AFFILIATION:

Papers

Masahiro Fukuoka's Publication Record

1. Personalized medicine and proteomics: lessons from non-small cell lung cancer. Year Published: 2007
Respiratory Biological Sciences, AstraZeneca R&D Lund, SE-221 87 Lund, Sweden.
2. Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002). Year Published: 2007
Department of Radiation Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan. ynishi@med.kindai.ac.jp
3. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation. Year Published: 2007
Department of Medical Oncology, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan.
4. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Year Published: 2007
Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan.
5. Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. Year Published: 2007
Heart and Stroke/Richard Lewar Centre for Excellence, University of Toronto.
6. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation. Year Published: 2007
Department of Medical Oncology, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan.
7. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Year Published: 2007
Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan. 105197@aichi-cc-jp
8. Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. Year Published: 2007
Heart and Stroke/Richard Lewar Centre for Excellence, University of Toronto.
9. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Year Published: 2008
Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan.
10. [Behavior of malignant tumor in bone. Bone Metastases in Lung Cancer.] Year Published: 2008
Shizuoka Cancer Center, Division of Thoracic Oncology.
11. A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer. Year Published: 2008
Okayama Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital, Okayama, Japan. kkiura@md.okayama-u.ac.jp